Suicide Preventive Psychosocial Treatment for Youths
2 other identifiers
interventional
282
1 country
5
Brief Summary
Suicide is the leading cause of death amongst 10-18-year-olds in Sweden. Suicide attempts are the strongest predictor of subsequent death by suicide, often lead to inpatient care, and are associated with substantial societal costs, making suicide attempts a critical target in psychiatric intervention research. Although youths attempting suicide are typically assessed and treated for potential comorbid psychiatric conditions, there is currently no trans-diagnostic evidence-based treatment specifically targeting suicidal behavior. To fill this gap, the Safe Alternatives for Teens and Youths (SAFETY) was developed. SAFETY is a transdiagnostic family-based cognitive-behavioral suicide prevention program that has shown promise but more studies are needed. The overall objective of this project is to evaluate the efficacy, durability, and cost-effectiveness of the SAFETY intervention, a scalable suicide prevention intervention that can be offered immediately following a youth suicide attempt, in a fully powered single-blind randomized controlled superiority trial. Our primary hypothesis is that the SAFETY intervention will be superior to Enhanced Treatment As Usual (enhanced with the evidence-based intervention safety planning) in reducing the proportion of suicide reattempts. Moreover, we predict that these improvements will be maintained for up to 60 months post-treatment. Finally, we expect that SAFETY will be cost-effective compared to the control intervention, both at the primary endpoint and in the longer term.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2025
Longer than P75 for not_applicable
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 7, 2025
CompletedFirst Posted
Study publicly available on registry
April 17, 2025
CompletedStudy Start
First participant enrolled
May 28, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2032
April 17, 2026
April 1, 2026
2.3 years
April 7, 2025
April 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Suicide Attempt - any report from the Columbia-Suicide Severity Rating Scale (C-SSRS) or electronic medical records
Any report of suicide attempt, using data collected from: 1. Youth-report of the C-SSRS. The C-SSRS is a 22-item structured clinical interview assessing the frequency and severity of suicidal ideation, suicidal behaviors, and self-harm. 2. Caregiver-report of the C-SSRS (reduced 4-item version including only the suicidal behavior section). 3. Electronic medical records.
Pre-treatment, immediately post-treatment, as well as 3-, 12-, 24- and 60-month post-treatment.
Secondary Outcomes (8)
Nonsuicidal self-injury - any report from The Deliberate Self Harm Inventory - Youth version (DSHI-Y)
Pre-treatment, immediately post-treatment, as well as 3-, 12-, 24- and 60-month post-treatment.
Work and Social Adjustment Scale, youth version (WSAS-Y)
Pre-treatment, immediately post-treatment, as well as 3-, 12-, 24- and 60-month post-treatment.
Children's global assessment scale (CGAS)
Pre-treatment, immediately post-treatment, as well as 3-, 12-, 24- and 60-month post-treatment.
Revised Children's Anxiety and Depression Scale, 25 item version (RCADS-25)
Pre-treatment, immediately post-treatment, as well as 3-, 12-, 24- and 60-month post-treatment.
Beck's Hopelessness Scale (BHS)
Pre-treatment, immediately post-treatment, as well as 3-, 12-, 24- and 60-month post-treatment.
- +3 more secondary outcomes
Other Outcomes (23)
Self-harm
Pre-treatment, immediately post-treatment, as well as 3-, 12-, 24- and 60-month post-treatment.
Borderline Personality Feature Scale for Children-11 (BPFS-C-11)
Pre-treatment
Levels of Personality Functioning Questionnaire 12-18 (LoPF-Q 12-18)
Pre-treatment
- +20 more other outcomes
Study Arms (2)
Safe Alternatives for Teens and Youth (SAFETY)
EXPERIMENTALSAFETY is a transdiagnostic cognitive-behavioral family treatment informed by Dialectical Behavior Therapy (DBT) and Multisystemic Therapy (MST). The twelve week long treatment is principle based, structured in phases, and individually tailored based on a cognitive-behavioral fit analysis that specifies key risk and protective processes. Each session contains one individual component for youth and parents respectively, and one family component where youth and parents work together with therapists to practice skills identified as critical for preventing future suicidal behavior. Treatment targets are arranged in a SAFETY Pyramid, consisting of (a) safe settings; (b) safe people; (c) safe activities and actions; (d) safe thought; and (e) safe stress reactions, emphasizing strengthening protective support and validation within the family and/or social environment surrounding the youth.
Enhanced Treatment As Usual
ACTIVE COMPARATOREnhanced Treatment As Usual (ETAU) consists of treatment as usual delivered by community clinicians enhanced by the evidence-informed Stanley-Brown Safety Planning Intervention, adapted for adolescents (e.g. involving both youth and parents) and to a Swedish context by the Swedish Association for Child and Adolescent Psychiatry and supervised by the research group. The adapted Safety Planning intervention include an assessment of current and future risk and protective factors for suicide, current and future suicide risk, and an individualized safety plan. We will ensure that the control intervention Safety Planning is delivered in a safe and comparable way across regions. Patients in both conditions will have access to standard care (including pharmaceutical treatment), as well as inpatient care as deemed necessary. The level of standard care will be carefully measured throughout the trial and included in statistical sensitivity analyses.
Interventions
Please see description of active comparator arm (arm two).
Please see description of experimental arm (arm one)
Eligibility Criteria
You may not qualify if:
- Symptoms obstructing participation in assessments or treatment
- Insufficient understanding of the Swedish language in youth and/or caregiver
- Enrolled in Dialectical Behavioral Therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
Child and Adolescent Mental Health Services, Region Skåne
Helsingborg, 25225, Sweden
Child and Adolescent Psychiatry, Region Värmland
Karlstad, Sweden
Child and Adolescent Mental Health Services, Region Halland
Kungsbacka, 301 85, Sweden
Child and Adolescent Mental Health Services, Region Stockholm
Stockholm, 118 51, Sweden
Child and Adolescent Psychiatry, Region Uppsala
Uppsala, Sweden
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Participants will be informed that they will be allocated to one of two psychosocial interventions addressing suicidality. Participants cannot be completely blinded; however, information about the two interventions will be kept to a minimum in the informed consent to avoid nocebo. Therapists who recruit participants and outcomes assessors will be blinded to the randomization sequence, and outcomes assessors will also be blinded to time-point. All participants will receive instructions not to reveal their treatment condition to the outcomes assessor. To assess the integrity of the blinded ratings, the blinded assessors will be instructed to record if the family accidentally revealed the condition, guess the participant's treatment allocation and motivation for their guess. If an assessor becomes unblinded, subsequent assessments for that participant will be conducted by a different assessor. Blinding will be broken after FU3 but masked assessors will remain blinded through follow-up.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
April 7, 2025
First Posted
April 17, 2025
Study Start
May 28, 2025
Primary Completion (Estimated)
September 1, 2027
Study Completion (Estimated)
September 1, 2032
Last Updated
April 17, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
Patient-level data are not publicly available due to national (Swedish) and EU legislation but could be made available from the corresponding author upon reasonable request following approval from the Swedish Ethical Review Authority.